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Abstract 
Objectives: African Americans are characterized by higher heart rate variability (HRV), a 
finding ostensibly associated with beneficial health outcomes. However, these findings are 
at odds with other evidence that ‘Blacks’ present with worse cardiovascular outcomes. 
Here we examine associations in a large cohort from the ELSA-Brasil study and 
determined whether these effects are mediated by discrimination.  
 
Methods: Three groups were compared based on self-declared race: 'Black' (n=2,020, 
'Brown' (n=3,502), and 'Whites' (n=6,467). Perceived discrimination was measured using a 
modified version of the Everyday Discrimination Scale. Resting-state HRV was extracted 
from 10-minute resting-state electrocardiograms. Racial differences in HRV were 
determined by regression analyses weighted by propensity scores, which controlled for 
potentially confounding variables including age, sex, education, and other health-related 
information. Non-linear mediation analysis quantified the average total effect, comprising 
direct (race – HRV) and indirect (race – discrimination – HRV) pathways.  
 
Results: ‘Blacks’ displayed higher HRV relative to ‘Browns’ (Cohen’s d = 0.20) and 
‘Whites’ (Cohen’s d = 0.31). ‘Browns’ also displayed a small, but significantly higher HRV 
relative to ‘Whites’ (Cohen’s d = 0.14). Discrimination indirectly contributed to the effects of 
race on HRV.  
 
Conclusions: This large cohort from the Brazilian population shows that HRV is greatest 
in 'Blacks' followed by 'Browns' relative to 'Whites.' The presence of higher HRV in 'Blacks' 
and 'Browns' may reflect a sustained compensatory psychophysiological response to the 
adverse effects of discrimination. Additional research is needed to determine the health 
consequences of these differences in HRV across racial and ethnic groups. 
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Introduction 
Non-communicable diseases including neuropsychiatric disorders and cardiovascular 
disease (CVD) are leading global burdens of disease [1, 2]. These diseases are 
responsible for 63% of all deaths worldwide, and 80% of these occur in low-and middle-
income countries [3]. In Brazil, an upper-middle-income country, morbidity and mortality 
due to non-communicable diseases are greatest in the most socioeconomically 
disadvantaged groups, and especially ‘Blacks’ [4-8]. A potential candidate marker for 
future ill-health is heart rate variability (HRV), an index of parasympathetic (vagal) function 
that may underpin psychophysiological flexibility, psychological wellbeing, health and 
longevity [9-11]. Reduced HRV is observed in the mood and anxiety disorders [12-17], and 
is associated with a 32-45% increased risk of a first cardiovascular event, even in 
populations without known CVD [18]. The vagus nerve plays an important regulatory role 
over a variety of allostatic systems including the hypothalamic-pituitary-adrenal axis [19], 
inflammatory processes [20], and glucose regulation [21, 22] [see also: 23-25]. 
Consequently, tonic vagal dysregulation – indexed using resting-state HRV – may lead to 
ill-health from a host of conditions and diseases including CVD [9, 10, 26, 27].  
 
It is unexpected therefore that vagally-mediated HRV in African Americans is higher – not 
lower – than HRV in ‘Whites’ [28]. These findings, based on a meta-analysis of 17 studies 
published between 1995 and 2013, were associated with a large effect size (Hedges g = 
0.93, 95% CI = 0.25-1.62). Higher HRV in African Americans represents a paradox 
because African Americans are also characterized by a high prevalence of cardiovascular 
morbidity and mortality [29, 30]. One potential explanation for increased HRV in ‘Blacks’ is 
a sustained, compensatory psychophysiological response to the adverse effects of 
discrimination, which include a worsening of blood pressure, cholesterol, body mass index 
and self-assessed general health [31, 32]. Consistent with this possibility, African 
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Americans display higher resting levels of systolic blood pressure and total peripheral 
resistance in combination with greater HRV in comparison to European Americans [33]. 
For the present study, we hypothesized that ‘Blacks’ and ‘Browns’ would display increased 
resting state HRV relative to ‘Whites’ in a large cohort from the Brazilian population. We 
also determined whether these racial differences in HRV would be mediated by 
discrimination consistent with a compensatory response.  
 
Methods 
Participants: ELSA-Brasil is a cohort of 15,105 civil servants aged 35-74 years enrolled 
between August 2008 and December 2010 at 6 different sites in Brazil (Belo Horizonte, 
Porto Alegre, Rio de Janeiro, Salvador, Sao Paulo and Vitoria). The ethics committees of 
the participating universities approved the research protocol. All participants provided 
written informed consent after a complete description of the study. Exclusion criteria 
comprised current or recent pregnancy (within 4 months of first interview), intention to quit 
working at the institution in the near future, severe cognitive or communication impairment, 
and if retired, residence outside of a study center’s metropolitan area. The study design 
and sampling procedures of ELSA-Brasil have been reported previously [34, 35] [36]. The 
present study focused on participants who self-reported their race including 6,467 ‘Whites’, 
3,502 ‘Browns’ and 2,020 ‘Blacks’, consistent with the classification adopted by the 2010 
National Brazilian Census. Racial measurement in the Brazilian census has always 
referred to phenotype (skin colour), not ancestry (origin), and the census has always 
included a term for the admixed population (“Pardo” or “Brown”), unlike the U.S. [37] Self-
declared race is a construct with sociopolitical significance that may capture unmeasured 
factors impacting on health outcomes. While we do not focus on health disparities here per 
se, our outcome measure (HRV) is medically important and may mediate downstream 
changes in a variety of allostatic systems. A total of 11,989 participants were available 
 7 
from the ELSA-Brasil cohort after dropping a relatively small number of participants who 
refused to self-report their race (n=184), participants who self-reported Asian (n=374) or 
indigenous ancestry (n=157), participants without available HRV exams (n=1813, including 
504 participants with ectopic beats, reflecting either extra or skipped beats on the ECG 
trace) and those participants missing data on other variables used in analysis (n= 653).  
 
Electrocardiogram Assessment 
Resting-state data from the electrocardiogram was recorded for ten-minutes during 
spontaneous breathing without task demands, in the supine position. The 
electrocardiogram was always collected in the morning (8:00 to 12:00h) in a temperature-
controlled room (21-24°C) and was sampled at 250 Hz with a digital electrocardiograph 
(Micromed, Brazil), consistent with international standards for the collection of HRV [38] 
[see also 39]. Wincardio (4.4a) software generated the R-R interval series from a selected 
lead (D2), which is associated with higher R-wave amplitude. Data was then processed to 
obtain high frequency (HF-HRV) using the autoregressive method as described elsewhere 
[40]. The HF-HRV (0.15–0.40 Hz) component was expressed in absolute units, and then 
log-transformed data as a normalization strategy [41]. The focus of our study is on HF-
HRV, a specific marker of vagal function [42].  
 
Discrimination Questionnaire 
Perceived discrimination was determined based on a modified version of the Everyday 
Discrimination Scale [43] (see also: 
http://scholar.harvard.edu/davidrwilliams/book/export/html/32495). This measure captures 
unfair treatment on 5 common experiences including: 1) the workplace such as being fired 
or not recommended for promotion (employment item), 2) difficulty in renting property or 
living within the community (housing item), 3) unfair accusation, being searched or 
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assaulted by the police (interactions with police item), 4) receiving poorer service within a 
public place such as a bank, shop, hospital or government office (discrimination in public 
places item), or 5) being (unfairly) discouraged within school or college (education item). 
For each situation, participants were asked whether they had experienced discrimination 
and responded on an ordinal scale. Available responses were ‘no’, ‘yes, one time’ and 
‘yes, more than one time’. Participants were then given a score of 0 if they did not 
experience discrimination, 1 if they reported experiencing any of these forms of 
discrimination once only, and a score of 2 if they had experienced any of these forms of 
discrimination on more than one occasion. Test-retest reliability (n=92, 2 weeks apart) [44] 
relating to overall discrimination is associated with a kappa coefficient of 0.85 (95%CI 0.72 
– 0.98). 
 
Covariates 
The present study sought to provide an important extension to the literature on the 
association between self-reported race and HRV. While the decision over what variables 
should be used as covariates is controversial [see 45], our decision was driven by the 
need to set the distributions of certain variables as equal across racial groups [46], 
allowing us to draw conclusions that the outcome – heart rate variability – is affected by 
race, rather than some other common, potentially confounding variable.  
 
Age, sex and education (less than high school, high school or college education) are 
commonly employed covariates. Each of these variables statistically differ by race (see 
participant characteristics) highlighting some degree of structural confounding, and are 
known to impact on HRV. Health related information also differs by race and therefore 
represents possible alternate pathways to alterations in HRV. Health related variables that 
were controlled in our study included smoking status (current versus past or never), 
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physical activity (measured using the International Physical Activity Questionnaire and 
categorized according to low activity versus moderate or high activity as determined using 
scoring guidelines: http://www.ipaq.ki.se/scoring.pdf), body mass index (weight in 
kilograms divided by height in meters squared, kg/m2) and medication use (including 
antidepressants, antihypertensive medications, and lipid lowering medications identified on 
the basis of pill bottle review). Additional health information on which groups were 
controlled included a continuous measure of psychiatric symptom severity determined 
using the Portuguese version [47] of the Clinical Interview Schedule-Revised (CIS-R) [47], 
hypertension (yes versus no; defined as systolic blood pressure ≥140 mm Hg, or diastolic 
blood pressure ≥ 90mm Hg, or use of antihypertensive medications), diabetes mellitus 
(yes versus no; defined as self-reported or fasting blood glucose ≥ 126mg/dL or 2-hour 
oral glucose tolerance test ≥ 200mg/dL or glycated haemoglobin ≥ 6.5%), dyslipidemia 
(yes versus no; defined as LDL-cholesterol ≥ 130mg/dL or use of lipid lowering 
medication), ‘hard’ coronary heart disease (including myocardial infarction and coronary 
revascularization) (yes versus no), and use of antidepressant medication (yes versus no).  
 
Statistical Analysis 
Statistical analyses were conducted using IBM SPSS Statistics Version 21 and R version 
3.0.1. Participant characteristics (Table 1) were examined using one-way analyses of 
variance (ANOVA) for contrasts involving continuous dependent measures, and χ2 
statistics for categorical variables in IBM SPSS Statistics Version 21. Tukey’s HSD is 
reported to correct for multiple comparisons and aid interpretation of ANOVA’s, while post 
hoc analyses were inspected to determine those groups that statistically differed from 
‘Whites’ in χ2 statistics. Propensity score weighted analysis and subsequent mediation 
analysis were conducted using R. These procedures are further described below and the 
R-code is provided in online supplementary information [see also 48, 49]. 
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Propensity score weighted analysis was used to control for potentially confounding 
variables (see above section on covariates) after which racial differences in HRV were 
determined. Propensity score analyses have several advantages over traditional 
regression-based analyses [48, 50]. Firstly, all covariates are summarized as a single 
propensity score providing an important dimension reduction tool for evaluating differences 
on the independent variable (e.g. race). Secondly, a formal model is explicitly specified 
that is not conflated with the modeling approach (i.e. the analysis on which conclusions 
are drawn). Thirdly, the propensity score is a function only of covariates, not outcomes 
(e.g. HRV), therefore repeated analyses attempting to balance covariate distributions 
across groups (e.g. race) do not bias estimates of the outcome (e.g. HRV). Fourthly, 
propensity score methods avoid extrapolating beyond the observed data unlike traditional 
parametric modeling when groups (e.g. race) are disparate on covariates.  
 
Weighted regression analyses were conducted using the ‘twang’ and ‘survey’ packages in 
the R statistical environment. Effective sample sizes (reported as ‘n’) were obtained from 
propensity score weighting, reflecting the numbers of participants with similar features on 
covariates in each of the groups. These effective sample sizes are smaller than the 
numbers of participants included in analyses as they capture the adverse impact of 
increased variance on precision and power [48]. Omnibus F-tests of statistical significance 
were conducted followed by t-tests to determine between group differences using the 
regTermTest and svydesign functions of the survey package [51]. The figure displays 
group means and 95% confidence intervals after propensity score weighting, extracted 
using the svyby function in the same package. Cohen’s d effect sizes were calculated 
using an online calculator (available here:  
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http://www.campbellcollaboration.org/escalc/html/EffectSizeCalculator-SMD8.php; based 
on [52]). A sensitivity analysis was then conducted to rule out any possibility that increased 
HRV in ‘Blacks’ is due to survival bias and under-representation of more severe disease 
due to premature cardiovascular death. Therefore sensitivity analysis involved re-doing our 
main analysis on younger individuals, as defined by those participants under the median 
age of the entire cohort. 
 
Following the propensity score weighted analysis, mediation analysis was conducted to 
determine whether discrimination mediates the effects of race on HRV, as proposed 
previously [28]. While mediation modeling has typically been conducted within a linear 
structural equation modeling framework, linear models cannot be used on ordinal data 
such as the discrimination variable in the present study. We employed the ‘mediation’ 
package [49] for mediation analyses, as this package provides a robust and flexible option 
for modeling non-linearity. Mediation allows the average total (𝜏̅) effect to be decomposed 
into average direct (𝜁)̅ and average indirect (𝛿̅) effects, and for hypotheses relating to the 
mediating effects of discrimination to be tested statistically. Direct, indirect and total effects 
are reported along with their uncertainty estimates based on 1000 nonparametric 
bootstrap resamples. Like that for our propensity score analyses (above), we also 
conducted sensitivity analysis to determine whether mediation could be replicated in the 
younger cohort, and in a cohort in which potential confounding variables will be less of a 
concern, especially ill-health and medication. Further sensitivity analyses were conducted 
on heart rate to determine whether discrimination mediated any relationship between race 
and this variable (see supplementary information).  
 
Results 
Participant Characteristics 
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Participant characteristics are presented in Table 1. Unadjusted analyses on the impact of 
race on HRV indicated that all groups significantly differed from each other, such that 
‘Blacks’ display higher HF-HRV than ‘Browns’, and ‘Browns’ display higher HF-HRV than 
‘Whites’. (See also the Table in supplementary information, which reports on unadjusted 
correlations between each participant characteristic and HRV measures). Propensity score 
weighting analyses (reported below) confirmed these unadjusted findings after controlling 
for potentially confounding variables. ‘Blacks’ also displayed a higher level of repeated 
discrimination, followed by ‘Browns’ relative to ‘Whites’. This finding provides the 
foundation on which results for mediation analyses is interpreted. 
 
INSERT TABLE 1 HERE 
 
Inspection of participant characteristics (Table 1) indicates that ‘Blacks’ and ‘Browns’ were 
slightly younger, and displayed more psychiatric symptoms (relative to ‘Whites’). None of 
the averaged CIS-R scores for race-based groupings reached the threshold required for 
diagnostic status (threshold score = 12; [47]). ‘Blacks’ (relative to ‘Whites’) were also 
heavier, more likely to be female, to have a lower level of education, to be physically 
inactive, to be current smokers, and to have a higher prevalence of hypertension, diabetes 
mellitus, and dyslipidemia. ‘Blacks’ (relative to ‘Whites’ and ‘Browns’) were also less likely 
to be using antidepressants. ‘Browns’ (relative to ‘Whites’) were more likely to have a 
lower level of education, to be physically inactive, to be current smokers, to have 
hypertension, diabetes mellitus, dyslipidemia and ‘hard’ CHD. Like ‘Blacks’, they were also 
less likely to be using antidepressants relative to ‘Whites’. These findings highlight the 
need for propensity score weighting, which allowed for differences on these covariates to 
be equalized across racial groupings.  
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Propensity Score Analysis 
Here we examined the impact of race on resting state HRV after propensity score 
weighting. Effective sample sizes were as follows: ‘Whites’, n=5,747; ‘Browns’, n=3,139; 
and ‘Blacks’, n=1,314. Significant effects were observed for HF-HRV [F(2,11986)=67.23, 
p= < 0.001]. ‘Blacks’ displayed higher vagally mediated HF-HRV (M = 5.60, 95% CI: 5.54, 
5.66) relative to ‘Whites’ (p < 0.001, Cohen’s d = 0.31; M = 5.23, 95% CI: 5.20, 5.26). In 
addition, ‘Blacks’ displayed higher vagally mediated HF-HRV relative to ‘Browns’ (p < 
0.001, Cohen’s d = 0.20; M = 5.39, 95% CI: 5.35, 5.44), while ‘Browns’ also displayed 
higher HF-HRV (M = 5.39, 95% CI: 5.35, 5.44) than ‘Whites’ (HF-HRV, p < 0.001, Cohen’s 
d = 0.14). (See Fig 1). 
 
INSERT FIG 1 HERE 
 
An additional sensitivity analysis was conducted on participants aged less than the median 
of the entire cohort (median age = 51.00 years) to rule out the possibility that greater HRV 
observed in ‘Blacks’ and ‘Browns’ relative to ‘Whites’ is due to survival bias. Effective 
sample sizes were as follows: ‘Whites’, n=2,959; ‘Browns’, n=1,807; and ‘Blacks’, n=792. 
Again, significant effects were observed for HF-HRV [F(2,6126)=32.20, p<0.001]. ‘Blacks’ 
displayed higher vagally mediated HF-HRV (M = 5.82, 95% CI: 5.75, 5.90) relative to 
‘Whites’ (p < 0.001, Cohen’s d = 0.29; M = 5.50, 95% CI: 5.45, 5.54). In addition, ‘Blacks’ 
displayed higher vagally mediated HF-HRV relative to ‘Browns’ (p < 0.001, Cohen’s d = 
0.16; M = 5.65, 95% CI: 5.60, 5.70). Finally, ‘Browns’ also displayed higher HF-HRV (M = 
5.65, 95% CI: 5.60, 5.70) than ‘Whites’ (p<0.001, Cohen’s d = 0.14). In summary, analyses 
revealed that the three groups differed from each other on HRV such that ‘Blacks’ 
displayed the highest HRV followed by ‘Browns’, and ‘Whites’, the group that displayed the 
lowest values. 
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Mediation Analysis 
Here we examined whether the relationship between race and HRV is mediated by 
discrimination. Results focusing on ‘Whites’ and ‘Blacks’ revealed significant total (𝜏̅= 
0.3590, 95% CI: 0.2980, 0.4147, p<0.01), direct (𝜁̅ = 0.3521, 95% CI: 0.2900, 0.4086, 
p<0.01) and indirect effects (𝛿 = 0.0069, 95% CI: 0.0010, 0.0143, p=0.02). Analysis on 
‘Whites’ and ‘Browns’ also revealed significant total (𝜏̅ = 0.1778, 95% CI: 0.1492, 0.2063, 
p<0.01) and direct effects (𝜁 ̅= 0.1751, 95% CI: 0.1462, 0.2034, p<0.01), but no indirect 
effect (𝛿 = 0.0027, 95% CI: -0.0006, 0.0057, p= 0.10). An analysis was also conducted on 
‘Browns’ and ‘Blacks’; results indicated significant total (𝜏̅  = 0.1820, 95% CI: 0.1521, 
0.2078, p<0.01) and direct (𝜁 ̅= 0.1767, 95% CI: 0.1475, 0.2028, p<0.01) effects, as well 
as an indirect effect at trend levels (𝛿 = 0.0053, 95% CI: 0.0001, 0.0100, p= 0.05).  
 
We then conducted a sensitivity analysis to determine whether mediation could be 
replicated in the younger cohort. Results from this sensitivity analysis focusing on ‘Whites’ 
and ‘Blacks’ revealed significant total (𝜏̅= 0.3347, 95% CI: 0.2572, 0.4090, p<0.01) and 
direct (𝜁 ̅= 0.3234, 95% CI: 0.2487, 0.3973, p<0.01) and an indirect effect at trend levels (𝛿 
= 0.0113, 95% CI: -0.0001, 0.0203, p= 0.06). Analysis on ‘Whites’ and ‘Browns’ also 
revealed significant total (𝜏̅ = 0.1623, 95% CI: 0.1256, 0.1981, p<0.01) and direct effects (𝜁 ̅
= 0.1593, 95% CI: 0.1230, 0.1943, p<0.01), but no indirect effect (𝛿 = 0.0030, 95% CI: -
0.0016, 0.0080, p=0.21). The sensitivity analysis on ‘Browns’ and ‘Blacks’ indicated 
significant total (𝜏̅ = 0.1704, 95% CI: 0.1357, 0.2063, p<0.01), direct (𝜁 ̅= 0.1629, 95% CI: 
0.1281, 0.1992, p<0.01) and indirect effects (𝛿  = 0.0075, 95% CI: 0.0008, 0.0152, p= 
0.03). In summary, mediation analysis revealed a small effect of discrimination in regards 
to the proportion of the mediated effect. Although small, this mediating effect of 
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discrimination significantly contributes to the race-related increase in HRV. Finally, 
additional sensitivity analysis (reported in supplementary information) revealed no 
significant mediating effect of discrimination for the relationship between race and heart 
rate. 
 
Discussion 
Recently published meta-analytic findings [28] indicate that African Americans display 
higher HRV relative to ‘Whites’, despite increased risk for cardiovascular morbidity and 
mortality among ‘Blacks’. The present study examined whether these findings extend to a 
large cohort from the Brazilian population, which may be less prone to residual 
confounding due to substantial racial admixture [53]. We also examined whether these 
findings are mediated by discrimination consistent with a compensatory response to the 
adverse effects of discrimination including hypertension [32] (see also Table 1). We 
observed that HRV is higher in ‘Blacks’ and ‘Browns’, relative to ‘Whites’, and that this 
finding is unlikely to be a consequence of survival bias as indicated by the sensitivity 
analysis on younger participants. Therefore, as per findings in African Americans [28], our 
findings in a Brazilian sample are a conundrum given the increased risk for morbidity and 
mortality that is most prominent in ‘Blacks’. We also present the first evidence – to our 
knowledge – that racial differences in HRV may be underpinned by the experience of 
repeated discrimination. 
 
Although discrimination is strongly associated with adverse physiological effects including 
hypertension [31, 32] (see also table 1), our findings also show that it may be associated 
with a sustained, compensatory psychophysiological response (see below). Although the 
parasympathetic (vagal) and sympathetic nervous systems (PNS and SNS) are typically 
conceptualized as two opposing components, this is not correct. Vagal activity – indexed 
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by HRV – may be co-activated or co-deactivated [54, 55]. While co-activation of the PNS 
and SNS activity may help to mitigate the deleterious effects of increased SNS activity 
[56], sympathetic-parasympathetic cardiac deactivation may reflect passive sensory intake 
[57]. Higher HRV in ‘Blacks’ may therefore reflect a compensatory response to the adverse 
physiological responses associated with perceived discrimination, which may include 
increased SNS activity. It is important to note that while ‘Blacks’ may display increased 
HRV, these alterations do not ameliorate other adverse physiological effects of 
discrimination [31, 32], which contribute to higher rates of morbidity and mortality caused 
by cardiovascular disease. An earlier study [33] demonstrated that African Americans – 
relative to European Americans – display greater HRV, in combination with higher resting 
levels of systolic blood pressure and total peripheral resistance (TPR). TPR was also 
increased and its recovery, delayed when anger was inhibited [33], and TPR may 
contribute to elevations in blood pressure and increased risk of morbidity and mortality [58, 
59]. These and other differences in vascular activity may therefore underpin the increased 
risk for CVD in ‘Blacks’ versus ‘Whites’. 
 
A notable feature of HRV is that it reflects psychological (e.g. emotion regulation) as well 
as physiological processes (e.g. control over allostatic systems), providing a structural link 
between mental and physical health [9]. While emotion regulation is a complex and multi-
dimensional construct that may also include rumination, we consider resting-state HRV to 
index capacity for emotion regulation reflecting effective prefrontal control of visceromotor, 
neuroendocrine, and behavioral responses, critical for goal-directed behavior, adaptability 
and health [11, 60, 61]. In this regard, higher HRV in ‘Blacks’ may reflect a heightened, yet 
forced capacity to regulate emotions associated with day-to-day stressors and 
discrimination against ‘Blacks’ and ‘Browns’. Some prior studies support this possibility. 
Firstly, ‘Blacks’ may be conditioned from an early age to inhibit their expression of anger in 
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an effort to reduce or avoid aggression [33], a consequence of early conditioning of 
avoidance learning in a social context [62, 63]. While inhibition of anger may be associated 
with more rapid blood pressure recovery, it is also associated with delayed TPR recovery, 
which may increase risk from hypertension-related death and disability [33]. Although we 
did not focus on hypertension here, it is notable that in our own sample that ‘Blacks’ 
display greater frequency of hypertension, followed by ‘Browns’ and ‘Whites’ (table 1). 
Furthermore, earlier research has demonstrated that racism-related vigilance represents 
an important source of chronic stress that contributes to this higher prevalence in 
hypertension [32]. Secondly, ‘Blacks’ are associated with a lower lifetime risk of mood and 
anxiety disorders, and that associated protective factors likely originate in childhood (prior 
to age 10) [64], as does learning to regulate emotions, according to the avoidance-learning 
hypothesis [33, 62, 63].  
 
Our study has several strengths including the investigation of HRV race-related differences 
in a large cohort characterized by substantial genetic admixture [53], the application of 
robust statistical techniques including propensity score weighted regression analyses and 
non-linear mediation analysis on which results are based, and confirmation of findings 
when only focusing on the younger cohort. We also demonstrate that although heart rate 
was decreased in ‘Blacks’ relative to ‘Browns’ and ‘Whites’, discrimination did not mediate 
the relationship between race and heart rate (see supplementary information), highlighting 
the specificity of the HRV findings that we report here. It is important to recognize here that 
resting-state HRV and the HF-HRV component in particular – unlike heart rate – is a 
relatively pure indicator of vagal activity [11, 65]. 
 
Several limitations of our work should also be noted. We did not collect data on respiratory 
rate or depth, which may influence estimates of HRV. However, the question over whether 
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they should be controlled – especially during resting state recordings – remains a divisive 
one in the field of psychophysiology [27, 66-68]. The use of a self-report measure of 
discrimination may also be considered a limitation, and we do not have any measure of 
emotion regulation, the ability to avoid anger or the frequency of anger episodes. In the 
future, researchers may wish to consider the possibility of using a variant of the implicit 
association test for assessing the unconscious experience of discrimination [69, 70]. 
Another limitation is the difficulty in quantifying the degree to which mediation analysis was 
robust to the possibility of unobserved confounding. Therefore, we adopt a balanced 
approach to inferring causation, presenting a theoretical set of relationships within a cross-
sectional dataset and interpret findings within the context of the available literature. 
Studies with longitudinal designs are necessary to further examine the pathways through 
which HRV is increased in ‘Blacks’ and ‘Browns’, as well as the downstream mechanisms 
that may underpin increased risks for cardiovascular morbidity in these individuals.  
 
We must also acknowledge that the proportion of variance explained by discrimination in 
our mediation analysis was small (the mediating effect was only 2-3% of the total effect). 
This small effect is perhaps unsurprising considering that 62% of the sample reported no 
experience of discrimination and that race-associated differences in HRV is likely to be 
multi-determinable. As suggested previously, it is possible that the conscious report of no 
discrimination in persons with fewer socioeconomic resources reflects a conscious 
decision not to report discrimination, or even internalized oppression that is not 
consciously perceived [69]. 
 
In conclusion, we demonstrate that ‘Blacks’ and ‘Browns’ display higher HRV relative to 
‘Whites’, findings that are partly mediated by discrimination. The race-based differences 
we observed in the present study may reflect a compensatory response to the adverse 
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physiological effects of discrimination. They may also reflect other factors including gene-
environment interactions and psychosocial issues on which further study is required. 
Future work in this area is necessary to further clarify the differences underpinning the 
observed race-related differences in HRV, as well as the mechanisms linked to race-
related health disparities. Our findings therefore lay an important foundation for future work 
that seeks to better understand the relationship between race and HRV, and the 
differential pathways to CVD.  
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Figure Captions 
 
Fig 1: HF-HRV (±95% confidence interval) by group. ‘Blacks’ display significantly higher 
values than ‘Browns’ who display significantly higher values than ‘Whites’.  
 
 
 
Figure Click here to download Figure Figure.jpg 
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Table: Unadjusted correlations (Pearson’s r or point biserial) between participant 
characteristics and HRV measures (HF-HRV, LF-HRV) for entire sample (N=11,989) to 
provide information about the size of the relationships.   
 
Characteristics, mean (SD) or N (%) HF-HRV LF-HRV 
Demographic variables   
Age -0.270 -0.301 
Female 0.091 -0.150 
Education 
  Less than high-school -0.059 -0.094 
  High School 0.043 -0.001 
Lifestyle characteristics   
Physical Inactivity -0.023 -0.059 
Current Smoker 0.035 -0.001 
Body mass index (kg/m2) -0.036 -0.080 
Discrimination3 0.081 0.036 
Health characteristics   
CIS-R Score1 0.030 -0.040 
Hypertension -0.140 -0.184 
Diabetes Mellitus -0.163 -0.171 
Dyslipidemia -0.086 -0.073 
Hard CHD2 -0.058 -0.079 
Antidepressant Use -0.102 -0.110 
Heart rate measures   
Heart rate (BPM) 4 -0.476 -0.366 
Supplementary Table - Correlations Click here to download Supplemental Data File (.doc, .xls, .jpg
etc.) Table - correlations.docx
 2 
HF-HRV [ln(msec2)] 1 0.628 
LF-HRV [ln(msec2)] 0.628 1 
 
1 CIS-R: Clinical Interview Schedule-Revised. 2 Hard CHD: Hard coronary heart disease 
includes myocardial infarction and coronary revascularization. 3 Experience of major 
discrimination in any of the 5 major experiences on more than one occasion. This 
combined measure of discrimination is used in the mediation model. 4 BPM: beats per 
minute 
Supplementary Information 
 
Propensity Score Analysis on Heart Rate 
In addition to the impact of race on resting state HF-HRV (reported in the manuscript), we 
examined impact on heart rate. Effective sample sizes were as follows: ‘Whites’, n=5,747; 
‘Browns’, n=3,139; and ‘Blacks’, n=1,314. Significant effects were also observed for heart 
rate [f(2,11986)=6.72, p=0.001] such that ‘Blacks’ displayed a slightly reduced HR [M= 
66.25, 95% CI: 65.77, 66.73] relative to ‘Whites’ (p<0.001, Cohen’s d = 0.11) (M = 67.25, 
95% CI: 67.01, 67.49), as well as ‘Browns’ (p=0.011, Cohen’s d = 0.08) (M = 67.01, 95% 
CI: 66.68, 67.33). However, no difference between ‘Browns’ and ‘Whites’ was observed. 
Notably effect sizes are smaller than those that are reported in the manuscript for HF-
HRV.  
 
Mediation Analysis 
Here we examined whether the relationship between race and heart rate is mediated by 
discrimination, to determine whether a similar mediating effect is obtained to that which we 
report in our manuscript. Results focusing on ‘Whites’ and ‘Blacks’ revealed significant 
total (𝜏̅= -1.2135, 95% CI: -1.6577, -0.7471, p<0.01) and direct effects (𝜁 ̅= -1.1626, 95% 
CI: -1.1694, -1.6199, p<0.01), but no indirect effect (𝛿 = -0.0441, 95% CI: -0.1012, 0.0109, 
p=0.10). Analysis on ‘Whites’ and ‘Browns’ also revealed significant total (𝜏̅ = -0.606393, 
95% CI: -0.854218, -0.380643, p<0.01) and direct effects (𝜁̅ = -0.586562, 95% CI: -
0.825550, -0.356875, p<0.01), but again no indirect effect was observed (𝛿 = -0.019831, 
95% CI: -0.047160, 0.000594, p= 0.06). An analysis was also conducted on ‘Browns’ and 
‘Blacks’; again results indicated significant total (𝜏̅ = -0.60155, 95% CI: -0.84210, -0.39233, 
p<0.01) and direct effects (𝜁̅ = -0.58348, 95% CI: -0.81342, -0.36749, p<0.01), but no 
indirect effect (𝛿 = -0.01807, 95% CI: -0.06092, 0.01680, p= 0.29). Therefore, unlike the 
Supplementary Results - Heart Rate Click here to download Supplemental Data File (.doc, .xls, .jpg
etc.) Supplementary Information - analysis on heart rate.docx
findings reported in the manuscript for HF-HRV, discrimination did not mediate the 
observed relationship between race and heart rate.  
 
 
######################### 
 
# Multiple propensity score matching for ethnicity - ETNIA variable: branca, 
parda, preta  
 
#code adapted from: Burgette et al., Propensity scores for multiple treatments: 
#A tutorial for the mnps function in the twang package  
 
######################### 
 
library(twang) 
set.seed(1) 
 
# reads in CSV datafile 
mydata <- read.table('/…/N = 11989.csv', header=TRUE, sep=",") 
 
#convert ETNIA to factor variable 
mydata$ETNIA <- factor(mydata$ETNIA, labels=c('branca','parda','preta')) 
 
# propensity score model of treatment assignment 
mnps.mydata.ATE <- mnps(ETNIA ~ AGEPART + RCTA8 + lessthanhs + high_school + 
Smoker + nofisica + IMCA01 + A_ESCORETOTAL + A_HAS2 + A_DM + DISLIP + HARDCHD + 
anyAdep, data = mydata, estimand = "ATE", verbose = FALSE, stop.method = 
c("es.mean", "ks.mean"), n.trees = 20000) 
 
# simple summary of balance 
means.table(mnps.mydata.ATE, digits = 3) 
 
# More extensive balance information 
bal.table(mnps.mydata.ATE) 
 
# Summary 
summary(mnps.mydata.ATE) 
 
################## 
 
# Analysis: Whites are set as controls 
 
################## 
 
require(survey) 
mydata$w <- get.weights(mnps.mydata.ATE, stop.method = "es.mean") 
design.mnps <- svydesign(ids=~1, weights=~w, data=mydata) 
 
# perform the propensity score-adjusted regression - heart rate with Whites as 
ref 
glm1 <- svyglm(DERAP_VFCCL_BPMmed_deitado ~ as.factor(ETNIA), design = 
design.mnps) 
summary(glm1) 
 
# clean printout of svyglm 
require(arm) 
display(glm1, digits=2, detail=TRUE) 
 
#substitute for anova - for df 
regTermTest(glm1, ~ as.factor(ETNIA)) 
 
# means for groups 
Supplemental Information - methods Click here to download Supplemental Data File (.doc, .xls, .jpg
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svyby(~DERAP_VFCCL_BPMmed_deitado, ~ ETNIA, svymean, design=design.mnps, 
vartype=c("se","ci","var"), na.rm=TRUE) 
 
# perform the propensity score-adjusted regression - lnHFms2 with Whites as ref 
glm1 <- svyglm(lnHFms2 ~ as.factor(ETNIA), design = design.mnps) 
summary(glm1) 
 
# clean printout of svyglm 
require(arm) 
display(glm1, digits=2, detail=TRUE) 
 
#substitute for anova - for df 
regTermTest(glm1, ~ as.factor(ETNIA)) 
 
# means for groups 
svyby(~lnHFms2, ~ ETNIA, svymean, design=design.mnps, 
vartype=c("se","ci","var"), na.rm=TRUE) 
 
################## 
 
# Analysis: Browns as controls 
 
################## 
 
# perform the propensity score-adjusted regression - heart rate with Browns as 
ref 
design.mnps$variables$ETNIA <- relevel(design.mnps$variables$ETNIA,ref="parda") 
glm1 <- svyglm(DERAP_VFCCL_BPMmed_deitado ~ as.factor(ETNIA), design = 
design.mnps) 
summary(glm1) 
 
# clean printout of svyglm 
require(arm) 
display(glm1, digits=2, detail=TRUE) 
 
#substitute for anova - for df 
regTermTest(glm1, ~ as.factor(ETNIA)) 
 
# means for groups 
svyby(~DERAP_VFCCL_BPMmed_deitado, ~ ETNIA, svymean, design=design.mnps, 
vartype=c("se","ci","var"), na.rm=TRUE) 
 
# perform the propensity score-adjusted regression - lnHFms2 with Browns as ref 
glm1 <- svyglm(lnHFms2 ~ as.factor(ETNIA), design = design.mnps) 
summary(glm1) 
 
# clean printout of svyglm 
require(arm) 
display(glm1, digits=2, detail=TRUE) 
 
#substitute for anova - for df 
regTermTest(glm1, ~ as.factor(ETNIA)) 
 
# means for groups 
svyby(~lnHFms2, ~ ETNIA, svymean, design=design.mnps, 
vartype=c("se","ci","var"), na.rm=TRUE) 
 
################## 
 # Analysis: Blacks as controls 
 
################## 
 
# perform the propensity score-adjusted regression - heart rate with Blacks as 
ref 
design.mnps$variables$ETNIA <- relevel(design.mnps$variables$ETNIA,ref="preta") 
glm1 <- svyglm(DERAP_VFCCL_BPMmed_deitado ~ as.factor(ETNIA), design = 
design.mnps) 
summary(glm1) 
 
# clean printout of svyglm 
require(arm) 
display(glm1, digits=2, detail=TRUE) 
 
#substitute for anova - for df 
regTermTest(glm1, ~ as.factor(ETNIA)) 
 
# means for groups 
svyby(~DERAP_VFCCL_BPMmed_deitado, ~ ETNIA, svymean, design=design.mnps, 
vartype=c("se","ci","var"), na.rm=TRUE) 
 
# perform the propensity score-adjusted regression - lnHFms2 with Blacks as ref 
glm1 <- svyglm(lnHFms2 ~ as.factor(ETNIA), design = design.mnps) 
summary(glm1) 
 
# clean printout of svyglm 
require(arm) 
display(glm1, digits=2, detail=TRUE) 
 
#substitute for anova - for df 
regTermTest(glm1, ~ as.factor(ETNIA)) 
 
# means for groups 
svyby(~lnHFms2, ~ ETNIA, svymean, design=design.mnps, 
vartype=c("se","ci","var"), na.rm=TRUE) 
 
 
######################### 
 
# MEDIATION with multiple covariates 
 
#code adapted from: Imai et al., Chapter 8: Causal Mediation Analysis Using R  
 
######################### 
 
library("mediation") 
 
# reads in CSV datafile 
mydata <- read.table("/…/N = 11989.csv", header=TRUE, sep=",") 
 
#convert dis_3grp to factor variable 
mydata$dis_3grp <- factor(mydata$dis_3grp) 
 
# Fit the mediator and outcome models using polr() and lm() functions 
# Note that the mediator here is fitted with an ordered probit model, polr(), as 
it is an ordered variable 
 med.fit <- polr(dis_3grp ~ ETNIA + AGEPART + RCTA8 + lessthanhs + high_school  + 
Smoker + nofisica + IMCA01 + A_ESCORETOTAL  + A_HAS2 + A_DM + DISLIP + HARDCHD + 
anyAdep, data = mydata, method = "probit", Hess = TRUE) 
 
out.fit <- lm(lnHFms2 ~ dis_3grp + ETNIA + AGEPART + RCTA8 + lessthanhs + 
high_school + Smoker + nofisica + IMCA01 + A_ESCORETOTAL + A_HAS2 + A_DM + 
DISLIP + HARDCHD + anyAdep, data = mydata) 
 
# Analysis will now take output objects from these models, med.fit and out.fit, 
and use them as inputs for the main function, mediate().  
# This mediate() function estimates the causal mediation effects, direct 
effects, and total effect along with their uncertainty estimates. 
 
# med.out refers to comparison between Blacks versus Whites 
med.out <- mediate(med.fit, out.fit, control.value = 1, treat.value = 3, sims = 
1000, boot = TRUE, treat = "ETNIA", mediator = "dis_3grp") 
 
# med.out2 refers to comparison between Browns versus Whites 
med.out2 <- mediate(med.fit, out.fit, control.value = 1, treat.value = 2, sims = 
1000, boot = TRUE, treat = "ETNIA", mediator = "dis_3grp") 
# med.out3 refers to comparison between Blacks versus Browns 
med.out3 <- mediate(med.fit, out.fit, control.value = 2, treat.value = 3, sims = 
1000, boot = TRUE, treat = "ETNIA", mediator = "dis_3grp") 
 
# The summary() function prints out the results of the analysis in tabular form: 
 
summary(med.out) 
summary(med.out2) 
summary(med.out3) 
 
# Note that sensitivity analysis is not able to be conducted when the polr() is 
used 
 
